Guidelines for diagnosis and treatment of patients with vasospastic angina (Coronary Spastic Angina) (JCS 2013).
暂无分享,去创建一个
[1] S. Akin,et al. A Broken Heart , 2014, Journal of cardiac surgery.
[2] S. Hokimoto,et al. Coronary Vasomotor Response to Intracoronary Acetylcholine Injection, Clinical Features, and Long‐term Prognosis in 873 Consecutive Patients With Coronary Spasm: Analysis of a Single‐Center Study Over 20 Years , 2013, Journal of the American Heart Association.
[3] H. Shimokawa,et al. Clinical implications of provocation tests for coronary artery spasm: safety, arrhythmic complications, and prognostic impact: multicentre registry study of the Japanese Coronary Spasm Association. , 2013, European heart journal.
[4] M. Shoda,et al. Guidelines for Non-Pharmacotherapy of Cardiac Arrhythmias (JCS 2011). , 2012, Circulation journal : official journal of the Japanese Circulation Society.
[5] M. Nishizaki,et al. Clinical implications of an implantable cardioverter-defibrillator in patients with vasospastic angina and lethal ventricular arrhythmia. , 2012, Journal of the American College of Cardiology.
[6] K. Kaikita,et al. Significance of coronary vasospasm in the perioperative management of non-cardiac surgery. , 2012, Circulation journal : official journal of the Japanese Circulation Society.
[7] HiroakiMatsubara,et al. Coronary Vasospasm Induced in Transgenic Mouse With Increased Phospholipase C-δ1 Activity , 2012 .
[8] J. Kaski,et al. High prevalence of a pathological response to acetylcholine testing in patients with stable angina pectoris and unobstructed coronary arteries. The ACOVA Study (Abnormal COronary VAsomotion in patients with stable angina and unobstructed coronary arteries). , 2012, Journal of the American College of Cardiology.
[9] M. Kawai,et al. Severe lasting coronary spasm detected by multi-detector row computed tomography. , 2011, International journal of cardiology.
[10] G. Watanabe,et al. Intraradial administration of fasudil inhibits augmented Rho kinase activity to effectively dilate the spastic radial artery during coronary artery bypass grafting surgery. , 2011, The Journal of thoracic and cardiovascular surgery.
[11] G. Schuler,et al. Clinical characteristics and cardiovascular magnetic resonance findings in stress (takotsubo) cardiomyopathy. , 2011, JAMA.
[12] K. Kitamura,et al. The impact of Rho-kinase inhibitor, “Fasudil”, intracoronary bolus administration to improve refractory coronary vasospasm , 2011, Cardiovascular intervention and therapeutics.
[13] H. Shimokawa,et al. Clinical Characteristics and Long-Term Prognosis of Vasospastic Angina Patients Who Survived Out-of-Hospital Cardiac Arrest: Multicenter Registry Study of the Japanese Coronary Spasm Association , 2011, Circulation. Arrhythmia and electrophysiology.
[14] T. Münzel,et al. Nitrate therapy: new aspects concerning molecular action and tolerance. , 2011, Circulation.
[15] K. Chayama,et al. Calcium channel blocker and Rho-associated kinase activity in patients with hypertension , 2011, Journal of hypertension.
[16] K. Okumura,et al. Comparison of the effects of long-acting nifedipine CR and diltiazem R in patients with vasospastic angina: Aomori coronary spastic angina study. , 2010, Journal of cardiology.
[17] H. Shimokawa,et al. Prognostic effects of calcium channel blockers in patients with vasospastic angina--a meta-analysis. , 2010, Circulation journal : official journal of the Japanese Circulation Society.
[18] T. Akasaka,et al. Guidelines for diagnosis and treatment of patients with vasospastic angina (coronary spastic angina) (JCS 2008): digest version. , 2010, Circulation journal : official journal of the Japanese Circulation Society.
[19] S. Umemura,et al. Simple and accurate electrocardiographic criteria to differentiate takotsubo cardiomyopathy from anterior acute myocardial infarction. , 2010, Journal of the American College of Cardiology.
[20] S. Umemura,et al. Digital assessment of endothelial function and ischemic heart disease in women. , 2010, Journal of the American College of Cardiology.
[21] C. Glueck,et al. Endothelial nitric oxide synthase T-786C mutation, a reversible etiology of Prinzmetal's angina pectoris. , 2010, The American journal of cardiology.
[22] Masato Nakamura,et al. Effects of treatment with once-daily nifedipine CR and twice-daily benidipine on prevention of symptomatic attacks in patients with coronary spastic angina pectoris-Adalat Trial vs Coniel in Tokyo against Coronary Spastic Angina (ATTACK CSA). , 2010, Journal of cardiology.
[23] Kenta Ito,et al. Role of Rho-kinase in the pathogenesis of coronary hyperconstricting responses induced by drug-eluting stents in pigs in vivo. , 2009, Journal of the American College of Cardiology.
[24] M. Yoshimura,et al. Severe coronary spasm occasionally detected by coronary computed tomography. , 2009, European heart journal.
[25] J. Lambert,et al. Association of ornithine transcarbamylase gene polymorphisms with hypertension and coronary artery vasomotion. , 2009, American journal of hypertension.
[26] A. Takeshita,et al. Rho-kinase is an important therapeutic target in cardiovascular medicine. , 2009, Arteriosclerosis, thrombosis, and vascular biology.
[27] O. Muller,et al. Interference of Drug-Eluting Stents With Endothelium-Dependent Coronary Vasomotion: Evidence for Device-Specific Responses , 2008, Circulation. Cardiovascular interventions.
[28] U. Sechtem,et al. Coronary artery spasm as a frequent cause of acute coronary syndrome: The CASPAR (Coronary Artery Spasm in Patients With Acute Coronary Syndrome) Study. , 2008, Journal of the American College of Cardiology.
[29] H. Kishida,et al. Administration of the Rho-kinase inhibitor, fasudil, following nitroglycerin additionally dilates the site of coronary spasm in patients with vasospastic angina , 2008, Coronary artery disease.
[30] T. Nakata,et al. Clinical implications of midventricular obstruction and intravenous propranolol use in transient left ventricular apical ballooning (Tako-tsubo cardiomyopathy). , 2008, American heart journal.
[31] M. Mishima,et al. Intracoronary nicorandil relieves multiple coronary vasospasm with hemodynamic collapse. , 2008, Circulation journal : official journal of the Japanese Circulation Society.
[32] K. Kaikita,et al. A novel genetic marker for coronary spasm in women from a genome-wide single nucleotide polymorphism analysis , 2007, Pharmacogenetics and genomics.
[33] T. Sakamoto,et al. Successful treatment of refractory angina pectoris due to multivessel coronary spasm with valsartan. , 2007, Internal medicine.
[34] K. Nakao,et al. The endothelial nitric oxide synthase gene -786T/C polymorphism is a predictive factor for reattacks of coronary spasm , 2007, Pharmacogenetics and genomics.
[35] Deepak L. Bhatt,et al. One-year cardiovascular event rates in outpatients with atherothrombosis. , 2007, JAMA.
[36] K. Maekawa,et al. Impaired endothelial vasomotor function after sirolimus-eluting stent implantation. , 2007, Circulation journal : official journal of the Japanese Circulation Society.
[37] H. Ogawa,et al. Prognostic value of flow-mediated dilation of the brachial artery in patients with cardiovascular disease. , 2006, Internal medicine.
[38] P. Fitzgerald,et al. Location of focal vasospasm provoked by ergonovine maleate within coronary arteries in patients with vasospastic angina pectoris. , 2006, The American journal of cardiology.
[39] H. Ogawa,et al. Sex differences of risk factors for acute myocardial infarction in Japanese patients. , 2006, Circulation journal : official journal of the Japanese Circulation Society.
[40] H. Kishida,et al. Vasodilatory effect of subsequent administration of fasudil, a rho-kinase inhibitor, surpasses that of nitroglycerin at the concentric coronary stenosis in patients with stable angina pectoris. , 2006, Circulation journal : official journal of the Japanese Circulation Society.
[41] J. Taguchi,et al. Coronary artery spasm and the polymorphisms of the endothelial nitric oxide synthase gene. , 2006, Circulation journal : official journal of the Japanese Circulation Society.
[42] K. Sunagawa,et al. Coronary Microvascular Dysfunction in Patients With Microvascular Angina: Analysis by TIMI Frame Count , 2005, Journal of cardiovascular pharmacology.
[43] H. Fukuda,et al. Need for documentation of guidelines for coronary artery spasm: an investigation by questionnaire in Japan. , 2005, Circulation journal : official journal of the Japanese Circulation Society.
[44] B. Cannon,et al. Nitric Oxide in the Evaluation of Congenital Heart Disease with Pulmonary Hypertension: Factors Related to Nitric Oxide Response , 2005, Pediatric Cardiology.
[45] O. Hess,et al. Sirolimus-eluting stents associated with paradoxic coronary vasoconstriction. , 2005, Journal of the American College of Cardiology.
[46] K. Nakao,et al. Increase in the transcriptional activity of the endothelial nitric oxide synthase gene with fluvastatin: a relation with the −786T>C polymorphism , 2005, Pharmacogenetics and genomics.
[47] Katherine C. Wu,et al. Neurohumoral features of myocardial stunning due to sudden emotional stress. , 2005, The New England journal of medicine.
[48] K. Iida,et al. Prognostic value of I-123 metaiodobenzylguanidine imaging in vasospastic angina without significant coronary stenosis. , 2005, Circulation journal : official journal of the Japanese Circulation Society.
[49] Jin Won Kim,et al. Delayed severe multivessel spasm and aborted sudden death after Taxus stent implantation , 2005, Heart.
[50] A. Lerman,et al. Systematic Review: Transient Left Ventricular Apical Ballooning: A Syndrome That Mimics ST-Segment Elevation Myocardial Infarction , 2004, Annals of Internal Medicine.
[51] H. Shimokawa,et al. Changing Characteristics of Patients with Vasospastic Angina in the Era of New Calcium Channel Blockers , 2004, Journal of cardiovascular pharmacology.
[52] H. Shimokawa,et al. Usefulness of Fasudil, a Rho-kinase Inhibitor, to Treat Intractable Severe Coronary Spasm after Coronary Artery Bypass Surgery , 2004, Journal of cardiovascular pharmacology.
[53] H. Fukuda,et al. Frequency of Provoked Coronary Spasms in Patients Undergoing Coronary Arteriography Using a Spasm Provocation Test Via Intracoronary Administration of Ergonovine , 2004, Angiology.
[54] H. Ogawa,et al. Endothelial dysfunction and coronary artery spasm. , 2004, Current drug targets. Cardiovascular & haematological disorders.
[55] HiroakiShimokawa,et al. Evidence for Protein Kinase C-Mediated Activation of Rho- Kinase in a Porcine Model of Coronary Artery Spasm , 2003 .
[56] J. Koyama,et al. Plaque morphology at coronary sites with focal spasm in variant angina: study using intravascular ultrasound. , 2003, Circulation journal : official journal of the Japanese Circulation Society.
[57] K. Nakao,et al. Synergistic interaction of T-786-->C polymorphism in the endothelial nitric oxide synthase gene and smoking for an enhanced risk for coronary spasm. , 2003, Pharmacogenetics.
[58] J. Yodoi,et al. Attenuation of Nitrate Tolerance and Oxidative Stress by an Angiotensin II Receptor Blocker in Patients With Coronary Spastic Angina , 2003, Circulation.
[59] I. Palacios,et al. Apical ballooning of the left ventricle: first series in white patients , 2003, Heart.
[60] Fernando Costa,et al. Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Ph , 2003, Circulation.
[61] Y. Nishimura,et al. Preference Toward a T-Helper Type 1 Response in Patients With Coronary Spastic Angina , 2003, Circulation.
[62] A. Steptoe,et al. Systematic review of mental stress-induced myocardial ischaemia. , 2003, European heart journal.
[63] M. Kondo,et al. Assessment of clinical features in transient left ventricular apical ballooning. , 2003, Journal of the American College of Cardiology.
[64] K. Miwa. Low density lipoprotein particles are small in patients with coronary vasospasm. , 2003, International journal of cardiology.
[65] K. Nishioka,et al. Usefulness of massive oral nicorandil in a patient with variant angina refractory to conventional treatment. , 2003, Internal medicine.
[66] N. Kanagy,et al. Acute and chronic NOS inhibition enhances alpha(2)- adrenoreceptor-stimulated RhoA and Rho kinase in rat aorta. , 2002, American journal of physiology. Heart and circulatory physiology.
[67] C. Kooperberg,et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.
[68] N. Ochi,et al. New protocol to detect coronary spastic angina without fixed stenosis. , 2002, Japanese heart journal.
[69] R. Karas,et al. The protective effects of estrogen on the cardiovascular system. , 2002, The New England journal of medicine.
[70] B. Strasberg,et al. Usefulness of implantable cardioverter-defibrillators in refractory variant angina pectoris complicated by ventricular fibrillation in patients with angiographically normal coronary arteries. , 2002, The American journal of cardiology.
[71] H. Tomita,et al. Enhanced Activity of Variant Phospholipase C-&dgr;1 Protein (R257H) Detected in Patients With Coronary Artery Spasm , 2002, Circulation.
[72] Masahiro Ito,et al. Limited role of coronary angioplasty and stenting in coronary spastic angina with organic stenosis. , 2002, Journal of the American College of Cardiology.
[73] A. Takeshita,et al. Suppression of Coronary Artery Spasm by the Rho-Kinase Inhibitor Fasudil in Patients With Vasospastic Angina , 2002, Circulation.
[74] K. Kugiyama,et al. Endothelial function fluctuates with diurnal variation in the frequency of ischemic episodes in patients with variant angina. , 2002, Journal of the American College of Cardiology.
[75] A. Takeshita,et al. Coronary microvascular spasm causes myocardial ischemia in patients with vasospastic angina. , 2002, Journal of the American College of Cardiology.
[76] K. Nishioka,et al. Tako-tsubo-like left ventricular dysfunction with ST-segment elevation: a novel cardiac syndrome mimicking acute myocardial infarction. , 2002, American heart journal.
[77] E. Benjamin,et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. , 2002, Journal of the American College of Cardiology.
[78] K. Kugiyama,et al. Menstrual Cyclic Variation of Myocardial Ischemia in Premenopausal Women with Variant Angina , 2001, Annals of Internal Medicine.
[79] A. Takeshita,et al. Three-year follow-up of the Japanese patients with microvascular angina attributable to coronary microvascular spasm. , 2001, International journal of cardiology.
[80] W. Sessa,et al. Acidic Hydrolysis as a Mechanism for the Cleavage of the Glu298 → Asp Variant of Human Endothelial Nitric-oxide Synthase* , 2001, The Journal of Biological Chemistry.
[81] H. Ogawa,et al. Transient left ventricular apical ballooning without coronary artery stenosis: a novel heart syndrome mimicking acute myocardial infarction. Angina Pectoris-Myocardial Infarction Investigations in Japan. , 2001, Journal of the American College of Cardiology.
[82] G. He,et al. Arterial grafts for coronary surgery: vasospasm and patency rate. , 2001, The Journal of thoracic and cardiovascular surgery.
[83] K. Kugiyama,et al. Estradiol supplementation suppresses hyperventilation-induced attacks in postmenopausal women with variant angina. , 2001, Journal of the American College of Cardiology.
[84] H. Ishizaka,et al. Enhanced phospholipase C activity in the cultured skin fibroblast obtained from patients with coronary spastic angina: possible role for enhanced vasoconstrictor response. , 2000, Journal of the American College of Cardiology.
[85] K. Kangawa,et al. Replication protein A1 reduces transcription of the endothelial nitric oxide synthase gene containing a -786T-->C mutation associated with coronary spastic angina. , 2000, Human molecular genetics.
[86] K. Kaibuchi,et al. Rho-Kinase Is Involved in Macrophage-Mediated Formation of Coronary Vascular Lesions in Pigs In Vivo , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[87] K. Nakao,et al. T(-786)--> C mutation in the 5'-flanking region of the endothelial nitric oxide synthase gene is associated with myocardial infarction, especially without coronary organic stenosis. , 2000, The American journal of cardiology.
[88] R. Erbel,et al. Safety of intracoronary Doppler flow measurement. , 2000, American heart journal.
[89] Seung‐Jung Park,et al. Intravascular ultrasound findings of negative arterial remodeling at sites of focal coronary spasm in patients with vasospastic angina. , 2000, American Heart Journal.
[90] S. Fichtlscherer,et al. Elevated C-Reactive Protein Levels and Impaired Endothelial Vasoreactivity in Patients With Coronary Artery Disease , 2000, Circulation.
[91] K. Kugiyama,et al. Diffuse intimal thickening of coronary arteries in patients with coronary spastic angina. , 2000, Journal of the American College of Cardiology.
[92] K. Kugiyama,et al. Improvement of endothelial function and insulin sensitivity with vitamin C in patients with coronary spastic angina: possible role of reactive oxygen species. , 2000, Journal of the American College of Cardiology.
[93] S. Yasuda,et al. Refractory coronary spasm relieved by intracoronary administration of nicorandil. , 2000, Japanese circulation journal.
[94] J. Moss,et al. Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[95] R. Mongiardo,et al. Major racial differences in coronary constrictor response between japanese and caucasians with recent myocardial infarction. , 2000, Circulation.
[96] K. Suzuki,et al. [Multi-vasospastic angina refractory to medical therapy caused by hyperthyroid stage of chronic thyroiditis and hypereosinophilia: a case report]. , 2000, Journal of cardiology.
[97] H. Sakuragi,et al. Acetylcholine‐ and ergonovine‐induced coronary microvascular spasm reflected by increased coronary vascular resistance and myocardial lactate production , 2000, Clinical cardiology.
[98] Y. Hirano,et al. Diagnosis of vasospastic angina by hyperventilation and cold-pressor stress echocardiography: comparison to I-MIBG myocardial scintigraphy. , 2000, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[99] K. Kugiyama,et al. Comparison of the risk factors for coronary artery spasm with those for organic stenosis in a Japanese population: role of cigarette smoking. , 2000, International journal of cardiology.
[100] H. Takaoka,et al. Systemic endothelial function is preserved in men with both active and inactive variant angina pectoris. , 1999, The American journal of cardiology.
[101] G. Newton,et al. Long-term endothelial dysfunction after coronary artery stenting. , 1999, Journal of the American College of Cardiology.
[102] A. Takeshita,et al. Rho-kinase-mediated pathway induces enhanced myosin light chain phosphorylations in a swine model of coronary artery spasm. , 1999, Cardiovascular research.
[103] J. Alpert,et al. ACC/AHA guidelines for ambulatory electrocardiography: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee to revise the guidelines for ambulatory electrocardiography). , 1999, Circulation.
[104] T. Utsunomiya,et al. Mental stress test is an effective inducer of vasospastic angina pectoris: comparison with cold pressor, hyperventilation and master two-step exercise test. , 1999, International journal of cardiology.
[105] R. Busse,et al. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation , 1999, Nature.
[106] K. Nakao,et al. T-786-->C mutation in the 5'-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. , 1999, Circulation.
[107] A. Maseri,et al. Racial heterogeneity in coronary artery vasomotor reactivity: differences between Japanese and Caucasian patients. , 1999, Journal of the American College of Cardiology.
[108] N. Ochi,et al. Frequency of provoked coronary vasospasm in patients undergoing coronary arteriography with spasm provocation test of acetylcholine. , 1999, The American journal of cardiology.
[109] P. Dendale,et al. Prinzmetal's variant angina: three case reports and a review of the literature. , 1999, Acta cardiologica.
[110] Masahiro Ito,et al. Abnormal fatty acid metabolism in patients with coronary vasospasm , 1999, Annals of nuclear medicine.
[111] N. Ochi,et al. Investigation of the most effective provocation test for patients with coronary spastic angina: usefulness of accelerated exercise following hyperventilation. , 1999, Japanese circulation journal.
[112] K. Kugiyama,et al. Vitamin E administration improves impairment of endothelium-dependent vasodilation in patients with coronary spastic angina. , 1998, Journal of the American College of Cardiology.
[113] K. Urabe,et al. Inappropriate microvascular constriction produced transient ST-segment elevation in patients with syndrome X. , 1998, Journal of the American College of Cardiology.
[114] K. Nakao,et al. A missense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese , 1998, Human Genetics.
[115] E. Vittinghoff,et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. , 1998, JAMA.
[116] T. Kondo,et al. [Clinical differences between variant and non-variant angina pectoris]. , 1998, Journal of cardiology.
[117] K. Kugiyama,et al. Vitamin C attenuates abnormal vasomotor reactivity in spasm coronary arteries in patients with coronary spastic angina. , 1998, Journal of the American College of Cardiology.
[118] C. Herzog,et al. Reversible myocardial contraction abnormalities in patients with an acute noncardiac illness. , 1998, Chest.
[119] H. Inoue,et al. Alterations of autonomic nervous activity preceding nocturnal variant angina: sympathetic augmentation with parasympathetic impairment. , 1998, American heart journal.
[120] A. Takeshita,et al. Angina pectoris caused by coronary microvascular spasm , 1998, The Lancet.
[121] K. Nakajima,et al. Value of iodine-123 metaiodobenzylguanidine scintigraphy in patients with vasospastic angina , 1998, European Journal of Nuclear Medicine.
[122] T. Kurosawa,et al. Sudden cardiac death in Japanese people aged 20-60 years--an autopsy study of 133 cases. , 1997, Japanese circulation journal.
[123] K. Kugiyama,et al. Coronary spasm: clinical features and pathogenesis. , 1997, Internal medicine.
[124] D. Pavin,et al. Human stress cardiomyopathy mimicking acute myocardial syndrome , 1997, Heart.
[125] K. Kugiyama,et al. Gender difference in improvement of endothelium-dependent vasodilation after estrogen supplementation. , 1997, Journal of the American College of Cardiology.
[126] K. Nakao,et al. Hyperventilation as a specific test for diagnosis of coronary artery spasm. , 1997, The American journal of cardiology.
[127] K. Kugiyama,et al. Long-lasting abnormalities in cardiac sympathetic nervous system in patients with coronary spastic angina: quantitative analysis with iodine 123 metaiodobenzylguanidine myocardial scintigraphy. , 1997, American heart journal.
[128] M. Shirotani,et al. Assessment of regional sympathetic nerve activity in vasospastic angina: analysis of iodine 123-labeled metaiodobenzylguanidine scintigraphy. , 1997, American heart journal.
[129] K. Kugiyama,et al. Supersensitive dilator response to nitroglycerin but not to atrial natriuretic peptide in spastic coronary arteries in coronary spastic angina. , 1997, The American journal of cardiology.
[130] K. Hirata,et al. Disparity between serotonin‐ and acetylcholine‐provoked coronary artery Spasm , 1997, Clinical cardiology.
[131] K. Kugiyama,et al. Menstrual cyclic variation of endothelium-dependent vasodilation of the brachial artery: possible role of estrogen and nitric oxide. , 1996, Proceedings of the Association of American Physicians.
[132] K. Morgan,et al. Mechanisms of smooth muscle contraction. , 1996, Physiological reviews.
[133] Yoshiharu Matsuura,et al. Phosphorylation and Activation of Myosin by Rho-associated Kinase (Rho-kinase)* , 1996, The Journal of Biological Chemistry.
[134] K. Nakao,et al. Nitric oxide activity is deficient in spasm arteries of patients with coronary spastic angina. , 1996, Circulation.
[135] Kozo Kaibuchi,et al. Regulation of Myosin Phosphatase by Rho and Rho-Associated Kinase (Rho-Kinase) , 1996, Science.
[136] H. Inoue,et al. Vitamin E deficiency in variant angina. , 1996, Circulation.
[137] M. Mazzari,et al. Low incidence of serotonin-induced occlusive coronary artery spasm in patients with recent myocardial infarction. , 1996, The American journal of cardiology.
[138] T. Murohara,et al. Effects of angiotensin-converting enzyme inhibitor alacepril in patients with stable effort angina during chronic isosorbide dinitrate treatment. , 1996, The American journal of cardiology.
[139] A. Logan,et al. Effect of reduced dietary sodium on blood pressure: a meta-analysis of randomized controlled trials. , 1996, JAMA.
[140] T. Kakuta,et al. Impaired glucose tolerance with late hypersecretion of insulin during oral glucose tolerance test in patients with vasospastic angina. , 1996, Journal of the American College of Cardiology.
[141] J. Deanfield,et al. Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults. , 1996, The New England journal of medicine.
[142] P. Serruys,et al. Progression and regression of coronary stenosis in the long-term follow-up of vasospastic angina. , 1995, Circulation.
[143] K. Nakajima,et al. Utility of iodine-123-BMIPP in the diagnosis and follow-up of vasospastic angina. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[144] K. Okumura,et al. Soluble P-selectin is released into the coronary circulation after coronary spasm. , 1995, Circulation.
[145] H. Takaki,et al. Insulin resistance associated with compensatory hyperinsulinemia as an independent risk factor for vasospastic angina. , 1995, Circulation.
[146] J. Koyama,et al. Comparison of vessel wall morphologic appearance at sites of focal and diffuse coronary vasospasm by intravascular ultrasound. , 1995, American heart journal.
[147] M. Fujita,et al. Susceptibility of plasma low density lipoprotein to cupric ion-induced peroxidation in patients with variant angina. , 1995, Journal of the American College of Cardiology.
[148] Y. Itai,et al. Usefulness of hyperventilation thallium-201 single photon emission computed tomography for the diagnosis of vasospastic angina. , 1995, Japanese heart journal.
[149] W E Haefeli,et al. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. , 1995, Circulation.
[150] H. Takano,et al. Regional myocardial sympathetic dysinnervation in patients with coronary vasospasm. , 1995, The American journal of cardiology.
[151] Satoshi Higa,et al. Enhanced insulin response relates to acetylcholine-induced vasoconstriction in vasospastic angina. , 1995, Journal of the American College of Cardiology.
[152] A. J. Wells. Passive smoking as a cause of heart disease. , 1994, Journal of the American College of Cardiology.
[153] A. Nitenberg,et al. Coronary artery constriction caused by the cold pressor test in human hypertension. , 1994, Hypertension.
[154] D. Spiegelhalter,et al. Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. , 1994, Journal of the American College of Cardiology.
[155] A. Tsubokawa,et al. [Induction of coronary artery spasm by combined cold pressor and hyperventilation test in patients with variant angina]. , 1994, Journal of cardiology.
[156] K. Kugiyama,et al. Comparison of the distribution of myocardial blood flow between exercise-induced and hyperventilation-induced attacks of coronary spasm: a study with thallium-201 myocardial scintigraphy. , 1994, American heart journal.
[157] T. Hoshino,et al. Assessment of quantitative exercise thallium-201 emission computed tomography in patients with vasospastic angina--value of washout rate analysis. , 1994, Japanese circulation journal.
[158] K. Kugiyama,et al. Influence of exercise-induced coronary artery spasm on thallium-201 initial distribution and washout kinetics in patients with variant and classic angina pectoris. , 1994, The American journal of cardiology.
[159] J. Isner,et al. Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women. , 1994, Circulation.
[160] M. Fujita,et al. Beneficial effects of smoking cessation on the short-term prognosis for variant angina--validation of the smoking status by urinary cotinine measurements. , 1994, International journal of cardiology.
[161] J. Koyama,et al. Intravascular ultrasound detection of atherosclerosis at the site of focal vasospasm in angiographically normal or minimally narrowed coronary segments. , 1994, Journal of the American College of Cardiology.
[162] K. Mizuno,et al. Angioscopy in variant angina: coronary artery spasm and intimal injury , 1993, The Lancet.
[163] K. Okumura,et al. Increased plasma plasminogen activator inhibitor activity after coronary spasm. , 1993, International journal of cardiology.
[164] A. Takeshita,et al. Clinical characteristics of patients with spontaneous remission of variant angina. , 1993, Japanese circulation journal.
[165] T. Giles,et al. Randomized placebo-controlled trial of amlodipine in vasospastic angina. Amlodipine Study 160 Group. , 1993, Journal of the American College of Cardiology.
[166] F. Takatsu,et al. Cigarette Smoking Is a Major Risk Factor for Coronary Spasm , 1993, Circulation.
[167] C. Hanet,et al. Vasomotor Response to Ergometrine and Nitrates of Saphenous Vein Grafts, Internal Mammary Artery Grafts, and Grafted Coronary Arteries Late After Bypass Surgery , 1992, Circulation.
[168] T. Nakamura,et al. Statistical analysis of clinical risk factors for coronary artery spasm: identification of the most important determinant. , 1992, American Heart Journal.
[169] D. Pryor,et al. Ergonovine maleate testing during cardiac catheterization: a 10-year perspective in 3,447 patients without significant coronary artery disease or Prinzmetal's variant angina. , 1992, Journal of the American College of Cardiology.
[170] K. Okumura,et al. Effect of acetylcholine on the highly stenotic coronary artery: difference between the constrictor response of the infarct-related coronary artery and that of the noninfarct-related artery. , 1992, Journal of the American College of Cardiology.
[171] M. Kern,et al. Smoking Is a Risk Factor for Coronary Spasm in Young Women , 1992, Circulation.
[172] K. Mizuno,et al. Angioscopic evaluation of coronary-artery thrombi in acute coronary syndromes. , 1992, The New England journal of medicine.
[173] J P Cooke,et al. Flow activates an endothelial potassium channel to release an endogenous nitrovasodilator. , 1991, The Journal of clinical investigation.
[174] K. Nakao,et al. Increased plasma level of endothelin-1-like immunoreactivity during coronary spasm in patients with coronary spastic angina. , 1991, The American journal of cardiology.
[175] M. Nobuyoshi,et al. Progression of coronary atherosclerosis: is coronary spasm related to progression? , 1991, Journal of the American College of Cardiology.
[176] S. Moncada,et al. Nitric oxide: physiology, pathophysiology, and pharmacology. , 1991, Pharmacological reviews.
[177] K. Mizuno,et al. Angioscopic coronary macromorphology in patients with acute coronary disorders , 1991, The Lancet.
[178] K. Okumura,et al. Fibrinopeptide A is released into the coronary circulation after coronary spasm. , 1990, Circulation.
[179] K. Kugiyama,et al. Coronary artery spasm: Japanese view , 1990 .
[180] K. Hirata,et al. Supersensitivity of isolated coronary artery to ergonovine in a patient with variant angina. , 1990, The American journal of medicine.
[181] K. Kugiyama,et al. Magnesium deficiency detected by intravenous loading test in variant angina pectoris. , 1990, The American journal of cardiology.
[182] A. Takeshita,et al. Exercise-induced silent myocardial ischemia in patients with vasospastic angina. , 1990, American heart journal.
[183] K. Okumura,et al. Responses of angiographically normal human coronary arteries to intracoronary injection of acetylcholine by age and segment. Possible role of early coronary atherosclerosis. , 1990, Circulation.
[184] D. Martínez-Caro,et al. The value of exercise testing in patients with coronary artery spasm. , 1990, American heart journal.
[185] A. Takeshita,et al. Clinical characteristics of sudden cardiac death in patients with vasospastic angina. , 1989, Japanese circulation journal.
[186] K. Okumura,et al. Circadian variation of plasma fibrinopeptide A level in patients with variant angina. , 1989, Circulation.
[187] D. Ardissino,et al. Hyperventilation and ergonovine tests in Prinzmetal's variant angina: comparative sensitivity and relation with the activity of the disease. , 1989, European heart journal.
[188] G. V. R. Born,et al. INFLUENCE OF PLAQUE CONFIGURATION AND STRESS DISTRIBUTION ON FISSURING OF CORONARY ATHEROSCLEROTIC PLAQUES , 1989, The Lancet.
[189] H. Drexler,et al. Flow-dependent coronary artery dilatation in humans. , 1989, Circulation.
[190] L. Ignarro,et al. Biological Actions and Properties of Endothelium-Derived Nitric Oxide Formed and Released From Artery and Vein , 1989, Circulation research.
[191] T. Aizawa,et al. Effect of nicorandil on coronary spasm. , 1989, The American journal of cardiology.
[192] K. Okumura,et al. Effect of magnesium on anginal attack induced by hyperventilation in patients with variant angina. , 1989, Circulation.
[193] K. Okumura,et al. Hyperventilation-induced simultaneous multivessel coronary spasm in patients with variant angina: an echocardiographic and arteriographic study. , 1988, Journal of the American College of Cardiology.
[194] K. Okumura,et al. Sensitivity and specificity of intracoronary injection of acetylcholine for the induction of coronary artery spasm. , 1988, Journal of the American College of Cardiology.
[195] M. Horie,et al. Long-term prognosis for patients with variant angina and influential factors. , 1988, Circulation.
[196] F. Zak,et al. Morphodynamic Interpretation of Acute Coronary Thrombosis, with Special Reference to Volcano-Like Eruption of Atheromatous Plaque Caused by Coronary Artery Spasm , 1988, Angiology.
[197] K. Kugiyama,et al. Multivessel coronary spasm in patients with variant angina: a study with intracoronary injection of acetylcholine. , 1988, Circulation.
[198] M. Nakamura,et al. Clinical characteristics and long-term prognosis of patients with variant angina. A comparative study between western and Japanese populations. , 1988, International journal of cardiology.
[199] H. Yasue,et al. Possible role of coronary spasm in acute myocardial infarction precipitated by hyperventilation. , 1988, British heart journal.
[200] D. Waters,et al. Long-term prognosis of patients with variant angina. , 1987, Circulation.
[201] J. Azuma,et al. Usefulness of Isosorbide Dinitrate Spray as an Angina Attack Relieving Agent , 1987 .
[202] A. Takeshita,et al. Clinical characteristics associated with myocardial infarction, arrhythmias, and sudden death in patients with vasospastic angina. , 1987, Circulation.
[203] A. Madeo,et al. Efficacy of diltiazem in variant angina. Results of a double-blind crossover study in CCU by Holter monitoring. The possible occurrence of a withdrawal syndrome. , 1987, Giornale italiano di cardiologia.
[204] S. Chierchia,et al. Induction of coronary artery spasm by a direct local action of ergonovine. , 1987, Circulation.
[205] R. Krone,et al. Comparison of electrocardiography and thallium-201 myocardial scintigraphy for the detection of ergonovine-induced coronary artery spasm: angiographic correlation. , 1987, American heart journal.
[206] T. Takakuwa,et al. [Clinical application of intracoronary administration of ergonovine for detecting vasospastic angina]. , 1987, Kokyu to junkan. Respiration & circulation.
[207] F. Crea,et al. Local coronary supersensitivity to diverse vasoconstrictive stimuli in patients with variant angina. , 1986, Circulation.
[208] K. Kugiyama,et al. Induction of coronary artery spasm by acetylcholine in patients with variant angina: possible role of the parasympathetic nervous system in the pathogenesis of coronary artery spasm. , 1986, Circulation.
[209] M. Nakamura,et al. Histamine-induced coronary spasm in regions of intimal thickening in miniature pigs: roles of serum cholesterol and spontaneous or induced intimal thickening. , 1986, Circulation.
[210] M. Bertrand,et al. Comparative results of percutaneous transluminal coronary angioplasty in patients with dynamic versus fixed coronary stenosis. , 1986, Journal of the American College of Cardiology.
[211] F. Crea,et al. Different susceptibility to myocardial ischemia provoked by hyperventilation and cold pressor test in exertional and variant angina pectoris. , 1985, The American journal of cardiology.
[212] D. Waters,et al. Percutaneous transluminal coronary angioplasty for the treatment of variant angina. , 1985, Journal of the American College of Cardiology.
[213] F E Harrell,et al. Clinical characteristics and long-term survival of patients with variant angina. , 1984, Circulation.
[214] M. Nakazawa,et al. Mechanism of relaxant effects of nicorandil on the dog coronary artery. , 1983, Archives internationales de pharmacodynamie et de therapie.
[215] M. Winniford,et al. Verapamil for unstable angina at rest: a short-term randomized, double-blind study. , 1983, American heart journal.
[216] K. Tanaka,et al. Coronary artery spasm induced in atherosclerotic miniature swine. , 1983, Science.
[217] M. Bertrand,et al. The provocation of coronary arterial spasm in patients with recent transmural myocardial infarction. , 1983, European heart journal.
[218] E. Falk. Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis. Characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi. , 1983, British heart journal.
[219] D. Waters,et al. Factors influencing the long-term prognosis of treated patients with variant angina. , 1983, Circulation.
[220] G. Vincent,et al. Coronary spasm producing coronary thrombosis and myocardial infarction. , 1983, The New England journal of medicine.
[221] H. Yasue,et al. Coronary Arterial Spasm in Ischemic Heart Disease and Its Pathogenesis: A Review , 1983, Circulation research.
[222] M. Bertrand,et al. Frequency of provoked coronary arterial spasm in 1089 consecutive patients undergoing coronary arteriography. , 1982, Circulation.
[223] D. J. Hayes,et al. Toxic effects of human eosinophil products on isolated rat heart cells in vitro. , 1982, The Biochemical journal.
[224] J. Kaski,et al. The hyperventilation test as a method for developing successful therapy in Prinzmetal's angina. , 1982, The American journal of cardiology.
[225] D. Waters,et al. Exercise Testing in Patients with Variant Angina: Results, Correlation with Clinical and Angiographic Features and Prognostic Significance , 1982, Circulation.
[226] G. Specchia,et al. The Exercise Test in Variant Angina: Results in 114 Patients , 1981, Circulation.
[227] S. Vatner,et al. Regulation of Large Coronary Arteries by Increases in Myocardial Metabolic Demands in Conscious Dogs , 1981, Circulation research.
[228] T. Itoh,et al. Effects of 2-nicotinamidoethyl nitrate on smooth muscle cells and on adrenergic transmission in the guinea-pig and porcine mesenteric arteries. , 1981, The Journal of pharmacology and experimental therapeutics.
[229] T. Itoh,et al. Vasodilating actions of 2-nicotinamidoethyl nitrate on porcine and guinea-pig coronary arteries. , 1981, The Journal of pharmacology and experimental therapeutics.
[230] H. Kishida,et al. Treatment of Variant Angina with Drugs: A Survey of 11 Cardiology Institutes in Japan , 1981, Circulation.
[231] R. Furchgott,et al. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine , 1980, Nature.
[232] R. Miller,et al. Provocation of Coronary Artery Spasm by the Cold Pressor Test: Hemodynamic, Arteriographic and Quantitative Angiographic Observations , 1980, Circulation.
[233] A. Maseri,et al. Long-term prognosis of "variant" angina with medical treatment. , 1980, The American journal of cardiology.
[234] S. Goldberg,et al. Refractory ergonovine-induced coronary vasospasm: importance of intracoronary nitroglycerin. , 1980, The American journal of cardiology.
[235] R. Macalpin,et al. Relation of coronary arterial spasm to sites of organic stenosis. , 1980, The American journal of cardiology.
[236] E. Antman,et al. Nifedipine therapy for coronary-artery spasm. Experience in 127 patients. , 1980, The New England journal of medicine.
[237] G. Specchia,et al. Coronary artery spasm of different degrees as cause of angina at rest with ST segment depression and elevation. , 1979, British heart journal.
[238] H. Yasue,et al. Circadian Variation of Exercise Capacity in Patients with Prinzmetal's Variant Angina: Role of Exercise‐induced Coronary Arterial Spasm , 1979, Circulation.
[239] J. Oates,et al. Comparative Assessment of Stimuli That Release Neuronal and Adrenomedullary Catecholamines in Man , 1979, Circulation.
[240] J. Kastor,et al. Coronary hemodynamic and myocardial metabolic alterations accompanying coronary spasm. , 1979, The American journal of cardiology.
[241] C. Conti,et al. Similarities of ergonovine-induced and spontaneous attacks of variant angina. , 1979, Circulation.
[242] T. Ryan,et al. ST-segment elevation during recovery from exercise. A new manifestation of Prinzmetal's variant angina. , 1978, Chest.
[243] H. Yasue,et al. Coronary Arterial Spasm and Prinzmetal's Variant Form of Angina Induced by Hyperventilation and Tris-buffer Infusion , 1978, Circulation.
[244] W. Kannel,et al. Death and coronary attacks in men after giving up cigarette smoking. A report from the Framingham study. , 1974, Lancet.
[245] H. Yasue,et al. Role of Autonomic Nervous System in the Pathogenesis of Prinzmetal's Variant Form of Angina , 1974, Circulation.
[246] H. B. Sprague. Emotional Factors in Coronary Heart Disease , 1961 .
[247] M. Prinzmetal,et al. Variant Form of Angina Pectoris: Previously Undelineated Syndrome , 1960 .
[248] M. Prinzmetal,et al. Angina pectoris. I. A variant form of angina pectoris; preliminary report. , 1959, The American journal of medicine.
[249] B. Gersh. 3-Year Follow-Up of Patients With Coronary Artery Spasm as Cause of Acute Coronary Syndrome: The CASPAR (Coronary Artery Spasm in Patients With Acute Coronary Syndrome) Study Follow-Up , 2012 .
[250] Kenta Ito,et al. Involvement of rho-kinase activation in the pathogenesis of coronary hyperconstricting responses induced by drug-eluting stents in patients with coronary artery disease. , 2012, Circulation journal : official journal of the Japanese Circulation Society.
[251] F. Crea,et al. Contemporary Reviews in Cardiovascular Medicine Mechanisms of Coronary Artery Spasm , 2011 .
[252] H. Kishida,et al. Variant angina and coronary artery spasm: the clinical spectrum, pathophysiology, and management. , 2011, Journal of Nippon Medical School = Nippon Ika Daigaku zasshi.
[253] Guidelines for Diagnosis and Treatment of Patients with Vasospastic Angina ( Coronary , 2010 .
[254] T. Saikawa,et al. Change in heart rate variability preceding ST elevation in a patient with vasospastic angina pectoris , 2007, Heart and Vessels.
[255] P. Serruys,et al. Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation. , 2006, European heart journal.
[256] K. Maekawa,et al. Images in cardiovascular medicine. Severe endothelial dysfunction after sirolimus-eluting stent implantation. , 2006, Circulation.
[257] H. Nonogi,et al. Successful treatment of refractory vasospastic angina with corticosteroids: coronary arterial hyperactivity caused by local inflammation? , 2004, Circulation journal : official journal of the Japanese Circulation Society.
[258] Hiroaki Shimokawa,et al. Rho-kinase inhibition with intracoronary fasudil prevents myocardial ischemia in patients with coronary microvascular spasm. , 2003, Journal of the American College of Cardiology.
[259] K. Nakao,et al. Genetic risk factors for coronary artery spasm: significance of endothelial nitric oxide synthase gene T-786-->C and missense Glu298Asp variants. , 2000, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.
[260] T. Aizawa,et al. Histological evaluation of coronary plaque in patients with variant angina: relationship between vasospasm and neointimal hyperplasia in primary coronary lesions. , 1999, Journal of the American College of Cardiology.
[261] K. Hirata,et al. 5-HT1Dbeta receptor mediates the supersensitivity of isolated coronary artery to serotonin in variant angina. , 1998, Chest.
[262] P. Touboul,et al. Arrhythmic cardiac arrest due to isolated coronary artery spasm: long-term outcome of seven resuscitated patients. , 1998, Journal of the American College of Cardiology.
[263] M. Okamoto,et al. Collateral flow detected by a Doppler guide wire in a case of vasospastic angina. , 1998, Internal medicine.
[264] H. Ishizaka,et al. Diffuse disorder of coronary artery vasomotility in patients with coronary spastic angina. Hyperreactivity to the constrictor effects of acetylcholine and the dilator effects of nitroglycerin. , 1996, Journal of the American College of Cardiology.
[265] R. Badenhop,et al. A smoking–dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene , 1996, Nature Medicine.
[266] M. Ishihara,et al. [Myocardial stunning due to simultaneous multivessel coronary spasms: a review of 5 cases]. , 1991, Journal of cardiology.
[267] D. Ardissino,et al. Hyperventilation and ergonovine tests in Prinzmetal's variant angina pectoris in men. , 1989, The American journal of cardiology.
[268] E. Nabel,et al. Dilation of normal and constriction of atherosclerotic coronary arteries caused by the cold pressor test. , 1988, Circulation.
[269] M. Nakamura,et al. Effects of nicorandil on rest and effort angina unresponsive to combination therapy with a calcium antagonist and oral nitrate. , 1987, Clinical therapeutics.
[270] M. Horie,et al. Variant angina induced by alcohol ingestion. , 1984, American heart journal.
[271] Y. Koga,et al. [Risk factors of coronary spasm]. , 1983, Nihon rinsho. Japanese journal of clinical medicine.
[272] Y. Uchida,et al. Effect of 2-nicotinamidethyl nitrate (SG 75) on coronary circulation. , 1978, Japanese heart journal.
[273] C. Jenkins,et al. Coronary heart disease in the Western Collaborative Group Study. A follow-up experience of 4 and one-half years. , 1970, Journal of chronic diseases.
[274] F. L. Hoch. Thyrotoxicosis as a disease of mitochondria. , 1962, The New England journal of medicine.
[275] W. Kannel,et al. Cigarette smoking and coronary heart disease. Combined experience of the Albany and Framingham studies. , 1962, The New England journal of medicine.